Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Phb3.3
Phenibut – Forschung
Überwiegend Mechanismus / Beobachtung
9 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu Phenibut sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus gemischt-qualitativen Studien, veröffentlicht 2001–2024.
Basierend auf 9 Studien
Konfidenz
Geringe Konfidenz
Nach Outcome
Dependence, withdrawal & overdose toxicity
Überwiegend Mechanismus / Beobachtung9 Studien
Anxiolysis (reported / short-term)Anwender und die ältere russische klinische Literatur berichten über eine verminderte Angst und Anspannung, was mit dem GABA-B-Agonismus übereinstimmt; Toleranz und Abhängigkeit entwickeln sich bei regelmäßiger Anwendung rasch · Innerhalb von Stunden nach einer Dosis
Überwiegend Mechanismus / Beobachtung5 Studien
Sedation & sleepPhenibut wirkt sedierend und wird häufig zur Schlafförderung eingesetzt; die GABAerge Sedierung ist real und dosisabhängig, birgt jedoch das Risiko von Abhängigkeit und Benommenheit am nächsten Tag · Innerhalb von Stunden nach einer Dosis
Überwiegend Mechanismus / Beobachtung3 Studien
Nootropic / sociability (reported)
Überwiegend Mechanismus / Beobachtung3 Studien
Aktives Forschungsgebiet
4 Studien in den letzten 5 Jahren
200120122024
1Systematische Übersicht2024
Further, clinicians may wish to consult an addiction specialist or toxicologist in these situations.
Penzak SR, Bulloch M. · Journal of clinical pharmacology (2024)
Phenobarbital may be preferred over baclofen, or used as an added agent, in patients at risk for seizures.
As long as phenibut remains legal, cases of phenibut intoxication and withdrawal are likely to increase.
As urine or plasma drug screening for phenibut is not widely available, it is vital that clinicians obtain a detailed medication history in patients presenting to the emergency department with nonspecific symptoms that may represent phenibut intoxication or withdrawal.
No deaths due to phenibut intoxication have been published in Germany or elsewhere in Western Europe, although such cases may have been overlooked, as this drug is still largely unknown to Western medicine.
Bonnet U, Scherbaum N, Schaper A, Soyka M. · Deutsches Arzteblatt international (2024)
Respiratory depression or coma was not encountered in any case, not even in the patient who had taken 100 g of phenibut.
Conclusion Phenibut causes symptoms resembling those of gabapentinoid and benzodiazepine use.
There have been reports of phenibut use in combination with other psychotropic drugs; in particular, its use together with opiates could increase the risk of coma and respiratory depression.
This review highlights the importance of collecting a thorough patient history, including supplements, to help prevent phenibut misuse and subsequent withdrawals.
Stewart C, Simonsen H, Satyasi SK, Ashraf N, Sukpraprut-Braaten S. · Cureus (2024)
The average age of patients with phenibut withdrawals was 31.8 years (SD=12.66 years), and 13 cases (87%) were males.
Nine cases (60%) presented at an emergency department, and three cases (17%) were presented at a clinic setting facility.
The most common history of patients who took phenibut was alcohol or drug abuse (73%).
Phenibut is a phenyl derivative of GABA ... It easily penetrates the brain. It is a tranquilizer and nootropic drug. Phenibut reduces ... tension, anxiety, and fear, improves sleep ... Phenibut is a GABA-B receptor agonist.
Lapin I. · CNS Drug Reviews (2001)
Foundational pharmacology review summarising phenibut as a Soviet-developed phenyl derivative of GABA that crosses the blood-brain barrier and acts principally as a GABA-B receptor agonist
Characterises its clinical use as a tranquiliser/nootropic — reducing tension, anxiety and fear and improving sleep — drawn largely from the older Russian literature
The closest thing to a 'mechanism of action' anchor for phenibut and the basis for its anxiolytic claims; methodologically a narrative review of mostly non-Western, limited clinical data
Phenibut is readily available to purchase over the internet ... Desired effects included anxiolysis, euphoria and improved sociability ... Acute toxicity included reduced level of consciousness, agitation and ... features consistent with a withdrawal syndrome.
Owen DR, Wood DM, Archer JR, Dargan PI. · Drug and Alcohol Review (2016)
Survey/analysis of phenibut's online availability, prevalence and patterns of use, the desired effects users seek, and its acute toxicity profile
Documents easy internet purchase and recreational use for anxiolysis, euphoria and sociability — the grey-market 'nootropic' use pattern in the West
Characterises acute toxicity including reduced consciousness and agitation, and features consistent with a withdrawal syndrome
We present a case of phenibut dependence and withdrawal ... characterized by severe psychomotor agitation and ... resolved with the use of baclofen ... Phenibut withdrawal can mimic baclofen withdrawal given their similar GABA-B agonist activity.
Ahuja T, Mgbako O, Katzman C, Grossman A. · Case Reports in Psychiatry (2018)
Case report of phenibut dependence and a severe withdrawal syndrome in a recreational/grey-market user, with management of withdrawal described
Withdrawal featured severe psychomotor agitation and was managed with baclofen substitution — the authors note phenibut withdrawal mimics baclofen withdrawal given shared GABA-B agonist activity
Frames phenibut among 'emerging nootropics of abuse' and links the GABA-B mechanism directly to the dependence/withdrawal liability
Phenibut ... is increasingly used as a nootropic and anxiolytic. We report a case of phenibut dependence and withdrawal ... clinicians should be aware of the dependence and withdrawal potential of this readily available substance.
Sethi R, Ravishankar DA, Nagireddy R. · The Primary Care Companion for CNS Disorders (2021)
Case report of phenibut dependence and withdrawal in a patient who obtained it as a readily available nootropic/anxiolytic
Reinforces the dependence and withdrawal potential and urges clinician awareness given easy online availability
Adds a third independent dependence/withdrawal case to the Western literature, the dominant signal for phenibut